Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Olfactory Mucosa

Below is an extended Olfactory Mucosa patents listing. Click here to return to the Olfactory Mucosa main in depth entry.

Patents :

US Patent No.Title
6140316 Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions
6606567 Methods for characterizing, classifying, and identifying unknowns in samples
6646109 Cloning and expression of a novel acetylcholine-gated ion channel receptor subunit
6647980 Method for administration of active substances to the olfactory region
6649618 Substituted amidoalkyl-uracils and their use
6663857 In vivo gene transfer using implanted retroviral producer cells
6663858 In Vivo gene transfer using implanted retroviral producer cells
6678553 Device for enhanced delivery of biologically active substances and compounds in an organism
6713293 Encapsulated cells containing an amplified expression vector as a drug delivery device
6741954 Selection method for odorants
6753323 Topical administration of amifostine and related compounds
6506801 Methods of treating anosmia and repopulating olfactory nerves with retinoids
6506378 Vesicular monoamine transporter gene therapy in Parkinson's disease
6451306 Methods for therapy of neurodegenerative disease of the brain
6167888 Method for inducing partial recovery of lost voluntary motor function after spinal cord injury in a mammal
6171575 Method of radioisotopic assessment of the integrity and function of the nose-brain barrier
6192882 Formulation and devices for monitoring the efficacy of the delivery of aerosols
6331534 Steroids as neurochemical stimulators of the VNO to alleviate pain
6344210 Composition for freshening nostrils and sinus cavities
6349719 Formulation and devices for monitoring the efficacy of the delivery of aerosols
6352980 Estrenes for inducting hypothalamic effects
6408250 Methods for characterizing, classifying, and identifying unknowns in samples
6410046 Administering pharmaceuticals to the mammalian central nervous system
6420337 Highly purified cytokine activating factor and methods of use
6924357 Lipid binding protein 4
6949245 Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
7427417 Aromatherapy delivery system
7435407 Inhibition of olfactory neurosensory function to treat eating disorders and obesity
7485302 Treatment with anti-ErbB2 antibodies and chemotherapeutic agents
7485619 Antimicrobial agent
7498030 Treatment with anti-ErbB2 antibodies and anti-hormonal compounds
7501122 Treatment with anti-ErbB2 antibody combinations
7537931 Humanized anti-ERBB2 antibodies and treatment with anti-ERBB2 antibodies
7557092 Purinergic modulation of smell
7604795 Nanoparticles for protein drug delivery
7604949 Methods and compositions that affect melanogenesis
7400927 Method and system for psychological treatment by brain stimulation of the psychologically disordered object
7381800 Antibodies to HBIMF63 polypeptide
7329745 Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth
6994671 Apparatus and method for screening, olfactory mucosa stimulating compound found by the screening method, and therapeutic apparatus and electrode section for measurement
7033598 Methods and apparatus for enhanced and controlled delivery of a biologically active agent into the central nervous system of a mammal
7041292 Treating prostate cancer with anti-ErbB2 antibodies
7087430 Human VNO cDNA libraries
7115258 Vesicular monoamine transporter gene therapy in parkinson's disease
7125995 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS)
7138107 Inhibition of olfactory neurosensory function to treat eating disorders and obesity
7200432 Device for enhanced delivery of biologically active substances and compounds in an organism
7202035 Genetic markers for skatole metabolism
7319138 Human DRG11-Responsive Axonal Guidance and Outgrowth of Neurite (DRAGON) proteins and variants thereof
7618631 Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.